Accessibility Menu
ProText Mobility logo

ProText Mobility(OTC) TXTM

Market Cap$32.53MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)+1,133%
5 Year+28%
1 Year-10%
1 Month-20%
$0.00
+5.41%
+0.00Today
ProText Mobility last closing stock price
MetricPriceDate
Last closeUSD 0.002026-08-13
ProText Mobility stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-7.5%USD 0.002026-08-06
1 month-19.57%USD 0.002026-07-14
3 month-47.89%USD 0.012026-05-15
Year to date+8.82%USD 0.002025-12-31
1 year-9.76%USD 0.002025-08-13
3 year+131.25%USD 0.002023-08-14
5 year+27.59%USD 0.002021-08-13
Since inception+1,133.33%USD 0.002017-01-03

ProText Mobility Financials at a Glance

Market Cap

$32.53MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

$497.44K

EPS (TTM)

$0.00

P/E Ratio

37.00

Dividend

$0.00

Beta (Volatility)

0.46 (Low)

Price

$0.00

Volume

13,197,549

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

N/A

TXTM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ProText Mobility

ProText Mobility, Inc. is a biotech company focused on developing pharmaceutical botanical medicines using highly-bioavailable plant extracts. Based in Fort Lauderdale, Florida, the company aims to innovate within the medical and pharmaceutical industry.

Products and Services
  • Development of pharmaceutical botanical medicines
  • Formulation of medicines with plant extracts
  • Focus on highly-bioavailable products
Growth Outlook
  • Market cap of approximately $8 million indicates potential for growth
  • Recent quarterly financials show a decrease in operating expenses
  • Innovative product offerings align with increasing demand for natural medicines
Financial Highlights
  • Trailing twelve months (TTM) price-to-earnings ratio of 41.5
  • Recent quarterly net income of -$17,555 reflects ongoing investment in growth
  • Quarterly operating expenses decreased from $22,817 to $16,000
ProText Mobility, Inc. operates in a niche market with a focus on botanical medicines, which are gaining traction in the healthcare sector. The company's innovative approach to utilizing plant extracts positions it well to capitalize on the growing consumer preference for natural and holistic health solutions. The financial data indicates a commitment to reducing operating expenses, which may enhance future profitability. With a market cap of around $8 million, there is significant room for growth as the company continues to develop its product offerings. The current price-to-earnings ratio suggests that investors are valuing the company's potential, despite recent net losses. Overall, ProText Mobility, Inc. presents an intriguing opportunity for those interested in the evolving landscape of the pharmaceutical industry.
AI Generated • Jul 21, 2026

Industry

Biotechnology

Sector

Health Care

Employees

30

CEO

Plooy Du Dylon

Website

www.sentryparentalcontrols.com

Headquarters

Fort Lauderdale, FL 33301, US

TXTM Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

0.00%

Return on Capital

-0.33%

Return on Assets

0.00%

Earnings Yield

2.70%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$32.53MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

8.79B

Volume

13.20M

Avg. Volume

7.44M

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$60.50K

EBITDA

-$60.50K

Operating Cash Flow

-$53.77K

Capital Expenditure

$0.00

Free Cash Flow

-$53.77K

Cash & ST Invst.

$0.00

Total Debt

$69.68K

ProText Mobility Performance Analysis

ProText Mobility annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
20252025-12-31USD 0N/A
ProText Mobility sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30N/A
Q32025-09-30N/A
Q42025-12-31N/A
Q12026-03-31N/A
ProText Mobility annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.00N/A
20232023-12-31USD 0.00N/A
20242024-12-31USD 0.00N/A
20252025-12-31USD 0.00N/A
ProText Mobility sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30N/A
Q32025-09-30N/A
Q42025-12-31N/A
Q12026-03-31-100.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$32.53MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.08M

N/A

Employees

30

N/A

Net Income

-$17.56K

-271.2%

EBITDA

-$16.00K

-340.9%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$0.00

N/A

Total Debt

$69.68K

+212.7%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$69.68K

+212.7%

Return on Assets

0.00%

N/A

Return on Invested Capital

0.00%

N/A

Free Cash Flow

-$10.81K

+36.8%

Operating Cash Flow

-$10.81K

+36.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BETRFBetterLife Pharma Inc.
$0.20-2.07%
CUBTCurative Biotechnology, Inc.
$0.97+4.64%
BIXTBioxytran, Inc.
$0.02-15.66%
BZYRBurzynski Research Institute, Inc.
$0.01+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$15.23+0.09%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.76+0.01%
ONDSOndas
$9.24+0.04%
SPCXSpace Exploration Technologies
$140.00-0.01%

Questions About TXTM

What is the current price of ProText Mobility?

ProText Mobility is trading at $0.00 per share.

What is the 52-week range for ProText Mobility?

Over the past 52 weeks, ProText Mobility has traded between $0.00 and $0.01.

How much debt does ProText Mobility have?

As of the most recent reporting period, ProText Mobility reported total debt of $159.24K.

How much cash does ProText Mobility have on hand?

ProText Mobility reported $0.00 in cash and cash equivalents in its most recent financial results.

What is ProText Mobility’s dividend yield?

ProText Mobility does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services